Overview

A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study Participants

Status:
COMPLETED
Trial end date:
2025-06-12
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the single-dose pharmacokinetics (PK) of 3 probe drugs (midazolam, bupropion, and metformin) before and after repeat doses of ZX008
Phase:
PHASE1
Details
Lead Sponsor:
UCB BIOSCIENCES, Inc.
Treatments:
Bupropion
Fenfluramine
Metformin
Midazolam